Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04633759 · ClinicalTrials.gov registry record · NA

Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04633759 is a NA study of Multiple Sclerosis that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04633759, a NA study of Multiple Sclerosis, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The Primary Aim of this research study is to determine the feasibility of 8 weeks of physical therapy strengthening exercises using blood flow restriction (BFR) in people with multiple sclerosis (MS) who have moderate-to-severe walking problems. BFR training involves placing a cuff on the leg being exercised in order to restrict blood flow. The cuff is attached to a specialized device that automatically detects the appropriate amount of pressure to place on the limb. Testing will occur before and after the 8-week treatment period.

Conditions Studied

Interventions

  • OTHER Blood Flow Restriction Exercise

Study Locations (1)

Colorado

  • University of Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-02-19
Est. Completion 2022-10-05
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT04633759

The ClinicalTrials.gov registry entry for NCT04633759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (97% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Blood Flow Restriction Exercise is the first listed.

NCT04633759 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04633759 about?

NCT04633759 is a clinical study titled "Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis". The Primary Aim of this research study is to determine the feasibility of 8 weeks of physical therapy strengthening exercises using blood flow restriction (BFR) in people with multiple sclerosis (MS) who have moderate-to-severe walking problems. BFR training involves placing a cuff on the leg being ...

What is the current status of trial NCT04633759?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-02-19. Estimated completion is 2022-10-05.

What conditions does trial NCT04633759 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT04633759?

The interventions under investigation include: Blood Flow Restriction Exercise (OTHER).

Who is sponsoring clinical trial NCT04633759?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04633759 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.